Authorship Rules
Authorship Rules previously voted
General Architecture (Transposed from CESAME)
- Author(A)1, A2, (+/- A3, A4 when additional external expertise is needed) ;
- 6 authors from the SC (not already at a better position in the byline)
- Consecutive blocks of 6 by alphabetic order when the first draft of each article is finalized
- Required committment for reviewing the draft and proposing when necessary alternative rephrasing
- Rotation of the 4 physicians of the Executive Committee (EC)
- Last author
- for the I-CARE Study Group:
- i.e. 13 to 15 authors
- Author (A)1, A2, (+/- A3, A4) and last author = Executive scientific team of the project
Authorship Rules final modalities
For Baseline paper
For the 4 major papers
For substudies
Collaborator Group
- 1 author per participating country and each country designates its representative
- Order of signature: decreasing number of included patients
- 15 authors in the middlle of the list of byline authors
1.Lymphoma in IBD / 2.Colorectal cancer and IBD treatments/ 3.Severe infection in IBD
4.Impact of biologics based strategies on the natural history of IBD and their potential for disease modification
- Rotation of 6 Nat Coord per major paper
- Order of country signature: decreasing number of included patients
What about a fifth ‘major’ paper on « All Cancers », which would allow each country to sign two times in the byline authors (6 x 5 = 30 = 2 x 15)?
- Same rules than major papers
- Proposed name: « The I-CARE collaborator group »
- Designation: First name Last name, hospital, university affiliation, city and country
Example: Laurent Beaugerie, Saint-Antoine Hospital, Sorbonne University, Paris France
- Organized by heading :
"National Coordinator", "Investigators Contributors", "Methodologists", "Coding Group", "Getaid Contributors", "Patients interaction contributors = SANOIA" , "Study Coordinators" etc.